tomeko

Spinal muscular atrophy-progressive myoclonic epilepsy syndrome

Just diagnosed with Spinal muscular atrophy-progressive myoclonic epilepsy syndrome?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, look for clinical trials, and connect with others living with it — all in one place.

Open the full Spinal muscular atrophy-progressive myoclonic epilepsy syndrome hub →

Overview

Spinal muscular atrophy-progressive myoclonic epilepsy syndrome is a rare condition. Also known as Hereditary myoclonus-progressive distal muscular atrophy syndrome, Jankovic-Rivera syndrome, SMA-PME. Tomeko brings together the specialists, research, clinical trials, treatments and community for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:2590 · OMIM 159950 · ICD-10 G25.3 · GARD 0003875

Find care for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome

Authoritative references for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome

Common questions

I was just diagnosed with Spinal muscular atrophy-progressive myoclonic epilepsy syndrome — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, filtered to your area.

Are there clinical trials for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome?

Tomeko shows live, recruiting studies for Spinal muscular atrophy-progressive myoclonic epilepsy syndrome from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com